{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:37:40Z","timestamp":1786991860055,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"funder":[{"name":"NIH","award":["CA140476"],"award-info":[{"award-number":["CA140476"]}]},{"name":"NIH","award":["CA172164"],"award-info":[{"award-number":["CA172164"]}]},{"name":"Dept. of Defense","award":["W81XWH-10-1-0290"],"award-info":[{"award-number":["W81XWH-10-1-0290"]}]},{"name":"Koch Institute Support"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["P30-CA14051"],"award-info":[{"award-number":["P30-CA14051"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jconrel.2013.05.037","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T15:03:09Z","timestamp":1370962989000},"page":"426-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes"],"prefix":"10.1016","volume":"172","author":[{"given":"Yiran","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias T.","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Annie","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuhbet","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianne","family":"Shearer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell J.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.05.037_bb0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0010","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0015","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0020","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0025","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0040","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1158\/1078-0432.CCR-10-0041","article-title":"Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients","volume":"16","author":"Besser","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0045","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jamcollsurg.2011.12.034","article-title":"Ex vivo interleukin-12-priming during CD8+ T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host","volume":"214","author":"Rubinstein","year":"2012","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/CJI.0b013e3181d367bd","article-title":"Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy","volume":"33","author":"Prieto","year":"2010","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0055","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00262-011-1021-7","article-title":"Phase I\/II study of adoptive transfer of gammadelta T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma","volume":"60","author":"Kobayashi","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0060","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1182\/blood-2009-09-241398","article-title":"IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice","volume":"115","author":"Markley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0065","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-10-0735","article-title":"Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts","volume":"70","author":"Kerkar","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0070","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1182\/blood-2006-06-029173","article-title":"Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene","volume":"109","author":"Hsu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0075","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0080","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1016\/j.biomaterials.2012.04.029","article-title":"Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles","volume":"33","author":"Stephan","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nano.2006.11.010","article-title":"A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells","volume":"3","author":"Fahmy","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.immuni.2010.03.015","article-title":"Reversal of autoimmunity by boosting memory-like autoregulatory T cells","volume":"32","author":"Tsai","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0095","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00109-011-0757-z","article-title":"Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a \u201cone size fits all\u201d approach?","volume":"89","author":"Clemente-Casares","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0100","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1479-5876-9-138","article-title":"Biomarkers in T cell therapy clinical trials","volume":"9","author":"Kalos","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.iy.11.040193.001333","article-title":"The IL-2 receptor complex: its structure, function, and target genes","volume":"11","author":"Minami","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0115","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/0008-5472.CAN-12-3343","article-title":"Localized immunotherapy via liposome-anchored anti-CD137+IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity","volume":"73","author":"Kwong","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0120","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","article-title":"Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions","volume":"181","author":"Baudino","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0125","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Overwijk","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0130","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.4049\/jimmunol.135.6.3988","article-title":"High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61","volume":"135","author":"Lowenthal","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0135","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/315669a0","article-title":"Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes","volume":"315","author":"Lowenthal","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0140","series-title":"Biological Engineering","article-title":"Liposome-anchored local delivery of immunomodulatory agents for tumor therapy","author":"Kwong","year":"2012"},{"key":"10.1016\/j.jconrel.2013.05.037_bb0145","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1083\/jcb.98.5.1757","article-title":"Endosome pH measured in single cells by dual fluorescence flow cytometry: rapid acidification of insulin to pH 6","volume":"98","author":"Murphy","year":"1984","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.it.2004.12.003","article-title":"Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy","volume":"26","author":"Klebanoff","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00002371-200205000-00007","article-title":"A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma","volume":"25","author":"Dudley","year":"2002","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2013.05.037_bb0160","first-page":"2009","article-title":"Pharmacokinetics of recombinant interleukin 2 in humans","volume":"50","author":"Konrad","year":"1990","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:30:12Z","timestamp":1759159812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913003295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0168365913003295"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.037","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}